Overview

Type 1 diabetes (T1D) can be a life-altering condition. Learn more about the epidemiology, burden of disease, and unmet needs for patients with T1D. Join us for a discussion on the progressive nature of T1D and review best practices for identifying which patients to screen for T1D autoantibodies, when to screen, and how to screen, including and monitoring the patient and/or caregiver after screening. Presented by Sanofi.

SPONSORED BY

Sanofi